Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
about
Tiotropium versus placebo for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisTiotropium versus placebo for chronic obstructive pulmonary diseaseStrategies for Management of the Early Chronic Obstructive Lung DiseaseBronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-AnalysisPharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDEarly chronic obstructive pulmonary disease: definition, assessment, and preventionUmeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a reviewNew combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesLung function decline in COPDOptimizing management of chronic obstructive pulmonary disease in the upcoming decade.Efficacy of tiotropium-olodaterol fixed-dose combination in COPDThe efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methodsEffect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosisSystematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsPrevalence of chronic obstructive lung disease in Korea using data from the fifth Korea national health and nutrition examination surveyEffect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data."Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD.Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerDevelopment and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trialsSpirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary diseasePneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education.Hospitalized patients with COPD: analysis of prior treatment.Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach.Influencing the decline of lung function in COPD: use of pharmacotherapy.Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.Right heart structural changes are independently associated with exercise capacity in non-severe COPDUpdate on the management of chronic obstructive pulmonary disease.Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial.Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD.Detection of airflow limitation using a handheld spirometer in a primary care setting.Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary diseaseTargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.Consider adding this drug to fight COPD that's severe.Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naïve to Maintenance Respiratory Therapy: A Study ProtocolAnnual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD
P2860
Q24194833-051291AC-24B9-40A9-8E76-9FD96115B9AFQ24197853-B6FEA5C5-FDA3-4391-AC8A-68BC57F5D783Q24202175-15672538-7D21-45AB-B864-38785146F4A8Q26739008-005766BB-D22D-47EA-8AB8-7A6AD5FCF37BQ26765486-3B1B2B68-549F-4575-84D2-9BFB2E732F79Q26778685-9105B106-AE72-4F21-A374-06D5E7653DEBQ26998557-7B50A836-45F0-4B03-93B4-FF1DB40322ABQ27015685-15E0039D-2A09-438D-9436-A3FEDCFA6EB7Q27024384-47CE7061-CB81-4BE7-8C0D-3B5908C870ADQ27024993-86956626-765F-45E9-B636-C64540C2E163Q27693341-F5C5A282-7E66-4840-8E4E-92BE43B83D33Q28075367-9D29CA95-DBC6-49A5-ACC3-CFBD92D70F37Q28085193-E6254BE6-86D3-4EE2-9EB3-6E1831445A3EQ28394883-6274C29E-58EE-4E7F-9DE3-ECBB69276EB9Q30245662-136241C0-B8AB-457D-B3E5-BBB8FEF60125Q30960435-2971E5D6-83AA-41BE-B529-115D618E50A9Q31012239-8CDAF354-1ACC-4572-B5C3-6F4A9BDCB4F6Q33693227-8B4FEDCB-AC04-420E-A8C5-2E7C536F1060Q33693426-E2A2CCB8-6CE5-4697-BD0E-1AD2B836C3D2Q33697687-EC76D7D1-3854-4F91-A4FC-4F885603BCCBQ33713847-A3E2CBDB-E876-46C8-A6D2-76FED06537D4Q33738733-51421B3F-CBA4-44CD-86C6-0B94FB9B0AFEQ33770577-96466DF3-E4E6-43F4-8DD5-EA0BBFEEA74FQ33942898-8C002695-3A0F-4195-94E9-CB19E85A97CDQ33943412-25B6CBEF-D30A-47CF-A7F2-F74E6EB9F752Q33966001-80BD5A26-5B5B-4572-B2FA-56D35B7C72B9Q34003435-2EA34DB0-0EBA-4F45-B5A4-E68CD1300F91Q34011640-162618D4-2001-4299-9D0A-D1EB9DE1285EQ34089229-597239DF-7D59-47F0-B93C-7BD91D61AEA2Q34119067-954051DC-A184-4C0F-9ABF-987BCC24792DQ34196174-8BE5529E-F86C-4214-8A1F-F042E6F122F9Q34369370-BBED541E-0A21-49B6-8350-EAA5AF2B5C10Q34500895-847E7B5F-3468-4D44-8FF7-B8A15E75E8F4Q34503139-B32B2585-9494-492F-A134-35E46B66DB2CQ34511113-2E818EA4-E4DF-4C1B-9BC1-A102794E0BAEQ34554816-199158A2-9580-4833-B6FE-CB4C40EA5D29Q34740635-C1887C40-4D40-4C28-9E02-BF652B320643Q34789599-AB75E321-5CF2-48FB-82ED-0DDF889EDFCEQ34807437-72EB9C97-7968-40E9-B802-1805DD47170EQ34823949-9F9E39E1-4537-4407-8D0D-92A8FD8644FD
P2860
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of tiotropium on outcom ...... a randomised controlled trial.
@en
Effect of tiotropium on outcom ...... obstructive pulmonary disease
@nl
type
label
Effect of tiotropium on outcom ...... a randomised controlled trial.
@en
Effect of tiotropium on outcom ...... obstructive pulmonary disease
@nl
prefLabel
Effect of tiotropium on outcom ...... a randomised controlled trial.
@en
Effect of tiotropium on outcom ...... obstructive pulmonary disease
@nl
P2093
P1433
P1476
Effect of tiotropium on outcom ...... a randomised controlled trial.
@en
P2093
Bartolome Celli
Donald P Tashkin
Marc Decramer
Steven Kesten
Sunil Mehra
UPLIFT investigators
P304
P356
10.1016/S0140-6736(09)61298-8
P407
P577
2009-08-27T00:00:00Z